IP Library Granted Patent US 11,536,714
Granted Patent B2
US 11,536,714 · App. 15/648,213 · Granted Dec 27, 2022

Compositions and methods of cell attachment

Inventors: Daniel Levner (Brookline, MA); Kyung Jin Jang (Andover, MA); Jacob Fraser (Somerville, MA); S. Jordan Kerns (Reading, MA); Antonio Varone (West Roxbury, MA); Dongeun Huh (Philadelphia, PA)
Assignee: EMULATE, INC.
G01N33/5032C07K2/00C07K14/78C12M23/16C12M23/20C12M25/02C12N5/0018C12N5/0068C12N5/067C12N5/0658G01N33/5014C12N2500/32C12N2521/00C12N2533/30C12N2533/50C12N2533/52C12N2533/54C12N2533/90C12N2535/10C12N2537/10G01N33/5044
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,536,714
App. No.
15/648,213
Granted
Dec 27, 2022
Kind
B2
Abstract

Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as mammalian cells, and/or for simulating a function of a tissue, e.g., a liver tissue, muscle tissue, etc. Extended adhesion and viability with sustained function over time is observed.

Claims (20)

1. A method of culturing cells, comprising:

a) providing a microfluidic device comprising a microchannel comprising a polydimethylsiloxane surface, said polydimethylsiloxane surface reacted with an ultraviolet light reactive portion of a N-sulfosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate heterobifunctional crosslinker using an ultraviolet light source, said microchannel in fluidic communication with a fluid source comprising a fluid;

b) covalently attaching one or more extracellular matrix proteins to a chemically-reactive portion of said heterobifunctional crosslinker so as to create a treated surface;

c) seeding viable epithelial cells on said treated surface so as to create attached epithelial cells;

d) flowing said fluid from said fluid source through said microchannel so as to create flowing conditions; and

e) culturing said attached epithelial cells under said flow conditions such that said attached epithelial cells remain attached and viable for at least 7 days.

2. The method of claim 1 , wherein said one or more extracellular matrix proteins comprises collagen.

3. The method of claim 1 , wherein said one or ore extracellular proteins comprises RGD or a RGD motif.

4. A method of culturing cells, comprising:

a) providing a microfluidic device comprising a microchannel comprising a polydimethylsiloxane surface, said surface reacted with an ultraviolet light reactive portion of a N-sulfosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate crosslinker using a source of ultraviolet light, said microchannel in fluidic communication with a fluid source comprising a fluid;

b) covalently attaching one or more extracellular matrix proteins to a chemically-reactive portion of said crosslinker so as to create a treated surface;

c) seeding viable hepatocytes on said treated surface so as to create attached cells;

d) flowing said fluid from said fluid source through said microchannel so as to create flowing conditions; and

e) culturing said attached cells under said flow conditions such that said cells remain attached and viable for at least 7 days.

5. The method of claim 4 , wherein said hepatocytes are dog hepatocytes.

6. The method of claim 4 , further comprising f) assessing viability of said hepatocytes by measuring the level of activity of one or more cellular enzymes.

7. The method of claim 6 , wherein said cellular enzyme is a cytochrome P450 (CYP) enzyme.

8. The method of claim 4 , wherein said one or more extracellular matrix proteins comprise collagen.

9. The method of claim 4 , wherein said one or more extracellular proteins comprises RGD or a RGD motif.

10. The method of claim 4 , wherein said polydimethylsiloxane surface is plasma treated prior to step b).

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2018
From: LEVNER, DANIEL; JANG, KYUNG JIN; FRASER, JACOB; KERNS, S. JORDAN; VARONE, ANTONIO; HUH, DONGEUN
To: EMULATE, INC.
Reel/Frame 045522/0750 →
Continuity (2)
Provisional Application 62361259 · Jul 12, 2016
Related Publication 20180024116A1 · Jan 25, 2018